Home Nucleus Pharmaceuticals U.S. Lung Transplant Therapeutics Market to 2032

U.S. Lung Transplant Therapeutics Market to 2032

Overview

The U.S. Lung Transplant Therapeutics Market is expected to reach a 116.55 USD Million by 2032 and is projected to grow at a CAGR of 7.68% from 2025 to 2032.

Revenue, 2024 (USD Million)
73.25
Forecast, 2032 (USD Million)
116.55
CAGR, 2024 - 2032
7.68%
Report Coverage
U.S.

U.S. Lung Transplant Therapeutics Market 2018-2032 USD Million

U.S. Lung Transplant Therapeutics Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 73.25 USD Million
  • Projected Market Size (2032): 116.55 USD Million
  • CAGR (2025-2032): 7.68%

Key Findings of U.S. Lung Transplant Therapeutics Market

  • The U.S. Lung Transplant Therapeutics Market was valued at 73.25 USD Million in 2024.
  • The U.S. Lung Transplant Therapeutics Market is likely to grow at a CAGR of 7.68% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Cadaveric Lung Transplant in Type Segment accounted for the largest share of the market with a revenue of 70.31 USD Million
  • The fastest growing segment Cystic Fibrosis in Indication Segment grew Fastest with a CAGR of 10.88% during the forecast period from 2024 to 2032.

U.S. Lung Transplant Therapeutics Market Scope

U.S. Lung Transplant Therapeutics Market Segmentation & Scope
Product
  • Others
  • Tissue Product
  • Organ Preservation Products
  • Immunosuppressant Drugs
Indication
  • Others
  • Septic Lung disease
  • Sarcoidosis
  • Emphysema
  • Primary Pulmonary Arterial Hypertension
  • Pulmonary Hypertension
  • Interstitial pulmonary fibrosis
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Pulmonary Fibrosis
  • Cystic Fibrosis
Type
  • Living Lung Transplant
  • Cadaveric Lung Transplant
Technique
  • Heart-Lung Transplant
  • Bilateral Lung Transplant (BLT)
  • Double Lung Transplant
  • Single-Lung Transplant (SLT)
Patient Demographics
  • Pediatric
  • Geriatric
  • Adults
End Users
  • Others
  • Specialty Centers
  • Transplant Centers
  • Hospital

U.S. Lung Transplant Therapeutics Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Million
Market Value in 2024 73.25 USD Million
Market Value in 2032 116.55 USD Million
CAGR (2025-2032) 7.68%
Historic Data 2016-2023
Market Segments Covered Product,Indication,Type,Technique,Patient Demographics,End Users

Regional Insights:

  • Leading Market (2024-2032): U.S., leading in terms of revenue 73.25 USD Million in 2024
    • Key Country: U.S., leading in terms of revenue with value of 73.25 USD Million in 2024.

Segments and Scope

  • U.S. Lung Transplant Therapeutics Market to 2032, By Product
    • Immunosuppressant Drugs is the largest segment in U.S. Lung Transplant Therapeutics Market to 2032 with a revenue of 56.60 USD Million in the year 2024.
    • Immunosuppressant Drugs is the Fastest growing segment in U.S. Lung Transplant Therapeutics Market to 2032 with a Growth rate of 7.94 % in forecast period 2025-2032.
  • U.S. Lung Transplant Therapeutics Market to 2032, By Indication
    • Cystic Fibrosis is the largest segment in U.S. Lung Transplant Therapeutics Market to 2032 with a revenue of 19.59 USD Million in the year 2024.
    • Cystic Fibrosis is the Fastest growing segment in U.S. Lung Transplant Therapeutics Market to 2032 with a Growth rate of 10.88 % in forecast period 2025-2032.
  • U.S. Lung Transplant Therapeutics Market to 2032, By Type
    • Cadaveric Lung Transplant is the largest segment in U.S. Lung Transplant Therapeutics Market to 2032 with a revenue of 70.31 USD Million in the year 2024.
    • Cadaveric Lung Transplant is the Fastest growing segment in U.S. Lung Transplant Therapeutics Market to 2032 with a Growth rate of 7.82 % in forecast period 2025-2032.
  • U.S. Lung Transplant Therapeutics Market to 2032, By Technique
    • Single-Lung Transplant (SLT) is the largest segment in U.S. Lung Transplant Therapeutics Market to 2032 with a revenue of 43.20 USD Million in the year 2024.
    • Single-Lung Transplant (SLT) is the Fastest growing segment in U.S. Lung Transplant Therapeutics Market to 2032 with a Growth rate of 8.30 % in forecast period 2025-2032.
  • U.S. Lung Transplant Therapeutics Market to 2032, By Patient Demographics
    • Adults is the largest segment in U.S. Lung Transplant Therapeutics Market to 2032 with a revenue of 41.44 USD Million in the year 2024.
    • Adults is the Fastest growing segment in U.S. Lung Transplant Therapeutics Market to 2032 with a Growth rate of 8.12 % in forecast period 2025-2032.
  • U.S. Lung Transplant Therapeutics Market to 2032, By End Users
    • Hospital is the largest segment in U.S. Lung Transplant Therapeutics Market to 2032 with a revenue of 50.59 USD Million in the year 2024.
    • Hospital is the Fastest growing segment in U.S. Lung Transplant Therapeutics Market to 2032 with a Growth rate of 7.96 % in forecast period 2025-2032.

U.S. Lung Transplant Therapeutics Market Company Share Analysis

 
Company Name Company Share Analysis
Viatris Inc.
ose-immuno
Panacea Biotec
Paragonix Technologies, Inc
NOVARTIS AG
U.S. Lung Transplant Therapeutics Market Company Share Analysis

U.S. Lung Transplant Therapeutics Market Geographical Sales Distribution, 2018-2032 USD Million

U.S. Lung Transplant Therapeutics Market Geographical Sales Distribution, 2018-2032 USD Million

U.S. Lung Transplant Therapeutics Market Company Profiling

U.S. Lung Transplant Therapeutics Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The U.S. Lung Transplant Therapeutics Market is segmented based on Segmentation Product,Indication,Type,Technique,Patient Demographics,End Users.
U.S. Lung Transplant Therapeutics Market was valued at USD 73.25(Revenue in USD Million) in 2022.
U.S. Lung Transplant Therapeutics Market is projected to grow at a CAGR of 7.68% during the forecast period of 2024 to 2032.
The Cadaveric Lung Transplant segment is expected to dominate the U.S. Lung Transplant Therapeutics Market, holding a largest market share of 70.31 USD Million in 2024

U.S. Lung Transplant Therapeutics Market Scope

U.S. Lung Transplant Therapeutics Market Segmentation & Scope
Product
  • Others
  • Tissue Product
  • Organ Preservation Products
  • Immunosuppressant Drugs
Indication
  • Others
  • Septic Lung disease
  • Sarcoidosis
  • Emphysema
  • Primary Pulmonary Arterial Hypertension
  • Pulmonary Hypertension
  • Interstitial pulmonary fibrosis
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Pulmonary Fibrosis
  • Cystic Fibrosis
Type
  • Living Lung Transplant
  • Cadaveric Lung Transplant
Technique
  • Heart-Lung Transplant
  • Bilateral Lung Transplant (BLT)
  • Double Lung Transplant
  • Single-Lung Transplant (SLT)
Patient Demographics
  • Pediatric
  • Geriatric
  • Adults
End Users
  • Others
  • Specialty Centers
  • Transplant Centers
  • Hospital
Frequently Asked Questions
The U.S. Lung Transplant Therapeutics Market is segmented based on Segmentation Product,Indication,Type,Technique,Patient Demographics,End Users.
U.S. Lung Transplant Therapeutics Market was valued at USD 73.25(Revenue in USD Million) in 2022.
U.S. Lung Transplant Therapeutics Market is projected to grow at a CAGR of 7.68% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Lung Transplant Therapeutics Market for final year is USD 116.55 (USD Million).

U.S. Lung Transplant Therapeutics Market Company Profiling

U.S. Lung Transplant Therapeutics Market Company Profiling
Frequently Asked Questions
The U.S. Lung Transplant Therapeutics Market is segmented based on Segmentation Product,Indication,Type,Technique,Patient Demographics,End Users.
U.S. Lung Transplant Therapeutics Market was valued at USD 73.25(Revenue in USD Million) in 2022.
U.S. Lung Transplant Therapeutics Market is projected to grow at a CAGR of 7.68% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Lung Transplant Therapeutics Market for final year is USD 116.55 (USD Million).

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES